

Media
Here you can read more about our latest media appearances, press releases and published articles that shine a spotlight on our work and innovations.
​
Also explore our latest posts on LinkedIn where we share news, insights and updates on our activities and progress.
Currently on LinkedIn
Here you will find our latest posts on LinkedIn where we share news, insights and updates about our activities and progress.
Press releases
​
​​​
​
Articles
Article Dietisten 2023-11-21. About how Evira is used at BUMM Norrtälje. https://www.dietisten.net/artiklar/Obesitas/matplatta-bra-vid-overvikt-och-obesitas-hos-barn
​
https://nyheter.ki.se/mobilapp-effektivt-stod-for-barn-med-obesitas
​
https://medtech4health.se/evira-ett-digitalt-werktyk-for-behandling-av-barnfetma/
​
https://sophianytt.se/artiklar/bast-pa-obesitasbehandling/
https://www.dn.se/sverige/fetma-bland-barn-okade-under-pandemin/
​
Participation in podcasts etc
Published research
”Long-term results of a digital treatment tool as an add-on topediatric obesity lifestyle treatment: a 3-year pragmaticclinical trial”, Emilia Hagman, Louise Lindberg, Resthie R. Putri, Andreas Drangel, Claude Marcus, Pernilla Danielsson, International Journal of Obesity, online 12 March 2025, doi: 10.1038/s41366-025-01738-0.
​
"Effect of an interactive mobile health support system and daily weight measurements for pediatric obesity treatment, a one-year pragmatical clinical trial" , Emilia Hagman, Linnea Johansson, Claude Kollin, Erik Marcus, Andreas Drangel, Love Marcus, Claude Marcus, Pernilla Danielsson , International Journal of Obesity, online 31 May 2022, doi: 10.1038/s41366-022-01146-8.
Thesis for doctoral degree(Ph.D) 2022. Mobile Health interventions and cardiorespiratory fitness in pediatric obesity. ​Linnea Johansson, Karolinska Institutet.
A novel interactive mobile health support system for pediatric obesity treatment: a randomized controlled feasibility trial. ​Linnea Johansson, Emilia Hagman, Pernilla Danielsson. BMC Pediatrics. 2020;20:447.
​
Evira has been used in clinical practice since 2018
Every day, patients and clinical staff use Evira in the treatment of childhood obesity.

4 500+
patients
Thousands of patients have received or are receiving help to treat their obesity with Evira today

1,5 years
average time in treatment
This indicates the median and average duration of treatment with Evira, varying based on factors such as the initial degree of obesity.

1 000 000+
measurments
Half a million measurements have been carried out in the safety of the patients' own homes

−0.3
BMI SDS
This is how much, on average, a patient reduces their BMI-SDS (measure of relative degree of overweight) after one year of treatment with Evira

7 000+
treatment years
Patients already contribute thousands of treatment years that we regularly analyze to make the tool and treatment better

50
clinics
This is how many clinics have used Evira for pediatric childhood obesity treatment i
five different countries
